Ivan Oransky
This person does not yet have a bio.
Articles by Ivan Oransky

Eye for Manipulation: A Profile of Elisabeth Bik
The microbiologist has turned her attention full-time to unearthing problematic figures in papers—for free.

Scientist Who Received Millions From NIH Leaves Alabama Posts
An investigation finds 20 papers by Santosh Katiyar, who studied alternative treatments for cancer, include image manipulation.

Opinion: Should Scientists Engage in Activism?
Scientists who accept funding with the tacit agreement that they keep their mouths shut about the government are far more threatening to an independent academy than those who speak their minds.

The Top 10 Retractions of 2014
A look at this year’s most memorable retractions

Top 10 Retractions of 2013
A look at this year’s most memorable retractions

Bring On the Transparency Index
Grading journals on how well they share information with readers will help deliver accountability to an industry that often lacks it.

A Jewish pig geneticist
Ivan Oransky | | 3 min read
Max Rothschild (left) in Uganda. Credit: courtesy of Max Rothschild" />Max Rothschild (left) in Uganda. Credit: courtesy of Max Rothschild The Rothschild lineage is often associated with Jewish tradition, banking, and fantastic wines. But Max Rothschild, a researcher at Iowa State University, is associated with some decidedly nonkosher animals: pigs. And, more recently, shrimp. When he was about 7 or 8 years old, Rothschild had a different kind

How The New York Times picks reporters
Ivan Oransky | | 1 min read
In a story that probably hit close to home to anyone who ever clicked on the wrong email recipient in Outlook, it turns out that attorneys for Lilly sent confidential documents to a New York Times reporter named Alex Berenson instead of an attorney named Bradford Berenson. Katherine Eban, who has linkurl:written for us;http://www.the-scientist.com/article/home/52963/ about biosecurity, linkurl:reported the story;http://www.portfolio.com/news-markets/top-5/2008/02/05/Eli-Lilly-E-Mail-to-New-York

Should trial sponsors pay for treatment?
Ivan Oransky | | 2 min read
What is the linkurl:responsibility of a company sponsoring a clinical trial;http://blogs.wsj.com/health/2008/01/31/when-drug-trials-go-wrong/ when one of its participants gets sick? That's the theme of a linkurl:story;http://online.wsj.com/article/SB120173515260330205.html in today's Wall Street Journal. As Sarah Rubenstein reports, the family of a woman who took part in a clinical trial of a drug for Parkinson's disease is suing the sponsors and university organizers of the trial. They say the

Science blogging conf.: Ethics, please
Ivan Oransky | | 2 min read
Do science bloggers need a code of ethics? Should they disclose conflicts of interest? Moderate comments? Protect anonymous colleagues? Those were some of the questions raised at the first session, led by linkurl:Janet Stemwedel, ;http://scienceblogs.com/ethicsandscience/ that I went to today at the linkurl:North Carolina Science Blogging Conference. ;http://wiki.scienceblogging.com/scienceblogging/ It's the second such conference, and I was stimulated enough by last year's to come back. (I ev

Do women blog about science?
Ivan Oransky | | 2 min read
When we asked readers who their linkurl:favorite science bloggers;http://www.the-scientist.com/news/home/53596/ were last year, we started the discussion by reaching out to a number of leading science bloggers. The bloggers who responded were all men, and most of the blogs they recommended were written by men. So perhaps understandably, GrrlScientist and others linkurl:wondered why we hadn't asked any women science bloggers about their favorites. ;http://scienceblogs.com/grrlscientist/2007/09/fa

Pygmy rabbits may get reprieve
Ivan Oransky | | 2 min read
For those of you cheering the linkurl:pygmy rabbit, ;http://www.the-scientist.com/article/display/53232/ you can let up a restrained cheer today - a small one, perhaps, in keeping with the size of the animals. The US Fish and Wildlife Service (USFWS), bowing to a linkurl:September court order, ;http://www.the-scientist.com/blog/display/53716/ is reconsidering whether more members of the tiny species should be covered under the Endangered Species Act. The agency had previously denied coverage of











